We use cookies to improve your experience on this website. Read More Allow Cookies

Our Researchers

About Dr Declan Soden

   Dr Declan Soden

Biography Summary

Dr. Soden has worked in the area of Immuno gene therapy and targeted delivery to tumours for the last decade. In that time his group has initiated several novel Phase I clinical trials, with currently over 500 patients having received a novel form of therapy for inoperable skin cancers.

Theme / Team

Immunotherapy, Electroporation, Novel Medical Devices

Cancer type(s)

Lung cancer, Melanoma, Pancreatic cancer, Colorectal cancer, Oesophageal cancer, Gastric cancer, Liver

Telephone

+353 (0) 21 420 5708

Email Address

d.soden@ucc.ie

Biography Detailed

Dr. Soden obtained his B.Sc. in molecular biology from UCC and completed a PhD investigating the regulation of gene expression. He completed his PhD at Lund University, Sweden before joining the CCRC. He worked as a Group Leader for the Centre in the area of gene and drug delivery from February 2003 and was responsible for running several clinical trials that involved the treatment of unresponsive cancers.

Dr. Soden has worked in the area of Immuno gene therapy and targeted delivery to tumours for the last decade. In that time his group has initiated several novel Phase I clinical trials, with currently over 500 patients having received a novel form of therapy for inoperable skin cancers.

His group a have developed a technology for the treatment of lung, liver, pancreatic and gastrointestinal tract cancers which facilitates a significant improvement in local drug or DNA absorption without the normally associated systemic side effects.

  • Patented medical devices for the minimally invasive electroporation assisted ablation of internal cancers     
  • Coordinator of CCRC engagement with an EU funded Cancer Network of excellence, links with 20 EU cancer centres
  • Awarded Irish Medicines Board approval to commence a Phase I trial using a new endoscopic system to treat colorectal cancer (November 2009) and lung cancer (April 2011).
  • Awarded Innovation of the Year award for 2011 based on Lung cancer work.
  • Awarded Pfizers Innovation through Teamwork award - 2014